Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

0.8911 -0.0987 (-9.97%)
Official Closing Price Updated: 7:00 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 66,206,132
Open 0.9800
Bid (Size) 0.9000 (1)
Ask (Size) 0.9100 (1)
Prev. Close 0.9898
Today's Range 0.8910 - 1.010
52wk Range 0.7403 - 2.545
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ginkgo Bioworks: Buy, Sell, or Hold?
This company has a long way to go before investors will see rewards. 
Via The Motley Fool
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today?
Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering. 
Via InvestorPlace

Performance

YTD
-46.64%
-46.64%
1 Month
-20.44%
-20.44%
3 Month
-29.83%
-29.83%
6 Month
-34.96%
-34.96%
1 Year
-24.48%
-24.48%

More News

Read More
Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock?
Via InvestorPlace
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest
Via Benzinga
Is Ginkgo Bioworks Stock a Buy?
Via The Motley Fool
Why Ginkgo Bioworks Stock Is Sinking Today
Via The Motley Fool
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Via Benzinga
Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks.
Via The Motley Fool
What's Going On With Ginkgo Bioworks Stock?
Via Benzinga
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
Via The Motley Fool
Earnings Scheduled For February 29, 2024
Via Benzinga
Earnings Outlook For Ginkgo Bioworks Holdings
Via Benzinga
Is Ginkgo Bioworks Stock a Buy Now?
Via The Motley Fool
The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
Via The Motley Fool
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
Via AB Newswire
Topics Supply Chain
Exposures Supply Chain
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
Via The Motley Fool
Is Ginkgo Bioworks Destined to Be in a "Magnificent Seven" of Healthcare Stocks?
Via The Motley Fool
S&P 500, Nasdaq 100 Hit Record Highs As Dollar, Treasury Yields Weaken, Chipmakers Shine, NYCB Sinks: What's Driving Markets Friday?
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Ginkgo Bioworks Stock Is Down After Earnings
Via Benzinga
Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
bit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network
From bit.bio
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.